Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
DELTA FLY PHARMA: Financial results presentation materials for the fiscal year ending 2024/3 20240515
May 15 02:10 ET
DELTA FLY PHARMA: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
Delta-Fly Pharma: Confirmation Letter
Feb 13 01:20 ET
Delta-Fly Pharma: Quarterly Report - 14th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Feb 13 01:17 ET
Read more
No Data